pyrrole condensate

product of D-glucosamine & ethyl acetoacetate which acts as an alloxan-diabetes factor in rats; structure given in first source

Also Known As:

ethyl-2-methyl-5-(D-arabinotetrahydroxybutyl)-3-pyrrole carboxylate; glucosamine acetoacetate condensate; 1H-Pyrrole-3-carboxylic acid, 2-methyl-5-(1,2,3,4-tetrahydroxybutyl)-, ethyl ester, (1R-(1R*,2S*,3R*))-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - pyrrole condensate: 1

Related Diseases

1.	Hyperglycemia 04/01/1980 - "Treatment with pyrrole condensate of obese diabetic mice, characterized by metabolic disturbances resembling diabetes mellitus in man, has resulted in the alleviation of classical diabetic symptoms, such as hyperglycemia, glycosuria, and low levels of liver glycogen."
2.	Glycosuria 04/01/1980 - "Treatment with pyrrole condensate of obese diabetic mice, characterized by metabolic disturbances resembling diabetes mellitus in man, has resulted in the alleviation of classical diabetic symptoms, such as hyperglycemia, glycosuria, and low levels of liver glycogen."
3.	Diabetes Mellitus 04/01/1980 - "Treatment with pyrrole condensate of obese diabetic mice, characterized by metabolic disturbances resembling diabetes mellitus in man, has resulted in the alleviation of classical diabetic symptoms, such as hyperglycemia, glycosuria, and low levels of liver glycogen."

Related Drugs and Biologics

1.	Liver Glycogen